# CHIO3 (NCT04062708)

> CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

No report yet. It can be ordered.

- Drugs tested: durvalumab
- Indication: operable stage IIIA/B non-small cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04062708
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Alliance Foundation Trials, LLC.
- Conditions: Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer
- Interventions: Durvalumab; Surgery; Radiotherapy
- Enrollment: 38
- Primary outcome: N2 Nodal Clearance (N2NC)

## Indexed commentary on CHIO3 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 7

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=chio3-nct04062708